Clinicopathologic Features and Response to Pembrolizumab Neoadjuvant Therapy in Triple Negative Breast Cancer (TNBC): A Single Institution Experience

被引：0
|
作者：
Carames, Gian [1 ]
Ning, Bohan [2 ]
Khoury, Katia [1 ]
Wei, Shi [3 ]
Xu, Jia [1 ]
Guo, Hua [2 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] UAB Hosp, Birmingham, AL USA
[3] Univ Kansas, Sch Med, Kansas City, KS USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy
    Ryan, P. D.
    Tung, N. M.
    Isakoff, S. J.
    Golshan, M.
    Richardson, A.
    Corben, A. D.
    Smith, B. L.
    Gelman, R.
    Winer, E. P.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Prospective evaluation of the gut microbiome and response to neoadjuvant therapy (NAT) in early-stage triple negative breast cancer (TNBC)
    Abuhadra, Nour
    Chang, Chia-Chi
    Yam, Clinton
    Sun, Ryan
    Huo, Lei
    White, Jason
    Ravenberg, Elizabeth E.
    Litton, Jennifer
    Lim, Bora
    Ueno, Naoto T.
    Arun, Banu
    Tripathy, Debu
    Damodaran, Senthil
    Murthy, Rashmi
    Valero, Vicente
    Hortobagyi, Gabriel
    Ibrahim, Nuhad
    Thompson, Alastair
    Mittendorf, Elizabeth
    Moulder, Stacy
    Jenq, Robert
    CANCER RESEARCH, 2021, 81 (04)
  • [33] A high rate of pathological complete response is possible by incorporating cisplatin in neoadjuvant therapy of locally advanced triple-negative breast cancer: A single-institution experience
    Georgy, J.
    Singh, A.
    Joel, A.
    Chacko, R.
    John, A.
    Ninan, F.
    Paul, A.
    John, G.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S60 - S60
  • [34] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
    McArthur, H. L.
    Basho, R.
    Shiao, S.
    Park, D.
    Dang, C.
    Karlan, S.
    Knott, S.
    Mita, M.
    Abaya, C. Dilauro
    Giuliano, A. E.
    Dadmanesh, F.
    Ho, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 86 - 86
  • [36] Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: A single institution experience.
    Glisch, Chad
    Jawa, Zeeshan Ali
    Badar, Talha
    Visotcky, Alexis
    Chaudhary, Lubna
    Kamaraju, Sailaja
    Burfeind, John D.
    Charlson, John A.
    Chitambar, Christopher R.
    Lagunova, Valentina
    Aguilera-Barrantes, Irene
    Jorns, Julie
    Cheng, Yee Chung
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
    McArthur, Hl
    Basho, R.
    Shiao, S. L.
    Park, D.
    Mita, M.
    Chung, A.
    Arnold, B.
    Martin, C.
    Dang, C.
    Karlan, S.
    Knott, S.
    Giuliano, A.
    Ho, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] A phase I study of pembrolizumab combined with ruxolitinib in triple negative breast cancer (TNBC)
    Almquist, Daniel
    CANCER RESEARCH, 2020, 80 (04)
  • [39] Response rates and toxicity profile of neoadjuvant immunotherapy in early-stage triple negative breast cancer (TNBC) - Multi institute experience
    Khalid, F.
    Attia, M.
    Mehmood, T.
    Shah, N.
    Baki, M.
    CLINICAL ONCOLOGY, 2025, 38
  • [40] Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
    Hashmi, Atif Ali
    Edhi, Muhammad Muzzammil
    Naqvi, Hanna
    Faridi, Naveen
    Khurshid, Amna
    Khan, Mehmood
    DIAGNOSTIC PATHOLOGY, 2014, 9
12345